Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies
Clinical trial NCT03654612 · UNKNOWN
Trial details
- NCT number
- NCT03654612
- Sponsor
- China International Medical Foundation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2020-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.